• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.

作者信息

Peschken Christine A

机构信息

University of Manitoba Arthritis Centre, Rady Faculty of Health Sciences, Winnipeg, Manitoba, Canada.

出版信息

J Rheumatol. 2020 Jun 1;47(6):787-790. doi: 10.3899/jrheum.200395. Epub 2020 Apr 8.

DOI:10.3899/jrheum.200395
PMID:32269064
Abstract
摘要

相似文献

1
Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.2019年冠状病毒病大流行期间羟氯喹短缺对系统性红斑狼疮患者的潜在后果
J Rheumatol. 2020 Jun 1;47(6):787-790. doi: 10.3899/jrheum.200395. Epub 2020 Apr 8.
2
Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.氯喹和羟氯喹治疗新冠病毒疾病的潜力引发了系统性红斑狼疮患者对药物短缺的担忧。
Nat Med. 2020 May;26(5):632. doi: 10.1038/s41591-020-0853-0.
3
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.系统性红斑狼疮患者基线使用羟氯喹并不排除感染SARS-CoV-2及发生重症新型冠状病毒肺炎。
Ann Rheum Dis. 2020 Oct;79(10):1386-1388. doi: 10.1136/annrheumdis-2020-217690. Epub 2020 May 7.
4
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.在 COVID-19 大流行期间使用羟氯喹和氯喹：每个临床医生都应该知道的事。
Ann Intern Med. 2020 Jun 2;172(11):754-755. doi: 10.7326/M20-1334. Epub 2020 Mar 31.
5
The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.新冠疫情期间羟氯喹短缺对皮肤病患者的影响。
Dermatol Ther. 2020 Jul;33(4):e13524. doi: 10.1111/dth.13524. Epub 2020 Jun 5.
6
Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic.羟氯喹：COVID-19大流行期间风湿病学家面临的潜在伦理困境。
J Rheumatol. 2020 Jun 1;47(6):783-786. doi: 10.3899/jrheum.200369. Epub 2020 Apr 2.
7
Considerations of Managing Lichen Planopilaris With Hydroxychloroquine During the COVID-19 Pandemic.
J Drugs Dermatol. 2020 Jun 1;19(6):679-680.
8
Regulators split on antimalarials for COVID-19.监管机构在用于治疗新冠肺炎的抗疟疾药物问题上存在分歧。
Lancet. 2020 Apr 11;395(10231):1179. doi: 10.1016/S0140-6736(20)30817-5.
9
The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.羟氯喹与 COVID-19 ：一个警示故事。
Ann Intern Med. 2020 Oct 20;173(8):662-663. doi: 10.7326/M20-5041. Epub 2020 Jul 16.
10
Does hydroxychloroquine combat COVID-19? A timeline of evidence.羟氯喹能对抗新冠病毒吗？证据时间表。
J Am Acad Dermatol. 2020 Jul;83(1):e33-e34. doi: 10.1016/j.jaad.2020.04.031. Epub 2020 Apr 10.

引用本文的文献

1
Psychosocial impact of SARS- CoV-2 outbreak on patients with pediatric-onset systemic lupus erythematosus and their caregivers.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫情对儿童期起病的系统性红斑狼疮患者及其照料者的心理社会影响
J Family Med Prim Care. 2022 Dec;11(12):7920-7925. doi: 10.4103/jfmpc.jfmpc_2112_21. Epub 2023 Jan 17.
2
COVID-19 in patients with systemic lupus erythematosus: A systematic review.COVID-19 与系统性红斑狼疮：系统综述。
Lupus. 2022 May;31(6):684-696. doi: 10.1177/09612033221093502. Epub 2022 Apr 5.
3
Post-traumatic stress disorder in patients with rheumatic disease during the COVID-19 outbreak: a cross-sectional case-control study in China.
COVID-19 疫情期间风湿性疾病患者的创伤后应激障碍：中国的一项横断面病例对照研究。
BMJ Open. 2022 Mar 30;12(3):e049749. doi: 10.1136/bmjopen-2021-049749.
4
Self medication practices and its determinants in health care professionals during the coronavirus disease-2019 pandemic: cross-sectional study.医护人员在 2019 冠状病毒病大流行期间的自我用药行为及其决定因素：横断面研究。
Int J Clin Pharm. 2022 Apr;44(2):507-516. doi: 10.1007/s11096-021-01374-4. Epub 2022 Jan 12.
5
Ivermectin for the Treatment of COVID-19 Disease: Too Good to Pass Up or Too Good to Be True?伊维菌素用于治疗新冠疾病：好到不容错过还是好到难以置信？
Open Forum Infect Dis. 2021 Jun 14;8(11):ofab318. doi: 10.1093/ofid/ofab318. eCollection 2021 Nov.
6
Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.慢性使用羟氯喹并未在巴西的一大群风湿疾病患者中预防 COVID-19。
Adv Rheumatol. 2021 Oct 7;61(1):60. doi: 10.1186/s42358-021-00217-0.
7
Challenges of Egyptian patients with systemic lupus erythematosus during the COVID-19 pandemic.埃及系统性红斑狼疮患者在新冠疫情期间面临的挑战。
Reumatologia. 2021;59(4):237-243. doi: 10.5114/reum.2021.108620. Epub 2021 Aug 20.
8
Fears about COVID-19 and perceived risk among people with rheumatoid arthritis or ankylosing spondylitis following the initial lockdown in Aotearoa New Zealand.新西兰首次封锁后，类风湿关节炎或强直性脊柱炎患者对 COVID-19 的担忧和感知风险。
Musculoskeletal Care. 2022 Jun;20(2):290-298. doi: 10.1002/msc.1585. Epub 2021 Aug 13.
9
[Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19].[羟氯喹：皮肤科的一种基本药物及其在 COVID-19 中的争议性应用]
Actas Dermosifiliogr. 2022 Feb;113(2):166-175. doi: 10.1016/j.ad.2021.07.005. Epub 2021 Aug 2.
10
COVID-19 Infection and Previous BCG Vaccination Coverage in the Ecuadorian Population.厄瓜多尔人群中新冠病毒感染情况与既往卡介苗接种覆盖率
Vaccines (Basel). 2021 Jan 27;9(2):91. doi: 10.3390/vaccines9020091.